Control of CD4 effector fate: transforming growth factor beta 1 and interleukin 2 synergize to prevent apoptosis and promote effector expansion
about
Transgenic modeling of transforming growth factor-beta(1): role of apoptosis in fibrosis and alveolar remodelingTransforming growth factor-beta 1 induces antigen-specific unresponsiveness in naive T cellsType 2 cytokines predominate in the human CD4(+) T-lymphocyte response to Epstein-Barr virus nuclear antigen 1.The TGF-beta-pseudoreceptor BAMBI is strongly expressed in COPD lungs and regulated by nontypeable Haemophilus influenzae.Antiretroviral cytolytic T-lymphocyte nonresponsiveness: FasL/Fas-mediated inhibition of CD4(+) and CD8(+) antiviral T cells by viral antigen-positive veto cells.Molecular and cellular mechanisms regulating T and B cell apoptosis through Fas/FasL interaction.CD4 T-cell memory can persist in the absence of class II.Functional and phenotypic changes in circulating lymphocytes from hospitalized zambian children with measles.Review article: molecular signals and genetic reprogramming in peripheral T-cell differentiation.Apoptosis within spontaneously accepted mouse liver allografts: evidence for deletion of cytotoxic T cells and implications for tolerance inductionEffector CD4 T-cell transition to memory requires late cognate interactions that induce autocrine IL-2.The timing of TGF-β inhibition affects the generation of antigen-specific CD8+ T cellsRapid default transition of CD4 T cell effectors to functional memory cellsCD8 T cell memory in B cell-deficient mice.Transforming growth factor beta1 inhibits Fas ligand expression and subsequent activation-induced cell death in T cells via downregulation of c-MycRequirement for transforming growth factor beta1 in controlling T cell apoptosisT cell death and transforming growth factor beta1IL-7 promotes the transition of CD4 effectors to persistent memory cells.Interleukin 2, but not other common gamma chain-binding cytokines, can reverse the defect in generation of CD4 effector T cells from naive T cells of aged mice.Unequal death in T helper cell (Th)1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis.CD4+ T-cell memory: generation and multi-faceted roles for CD4+ T cells in protective immunity to influenza.Transforming growth factor-beta suppresses the activation of CD8+ T-cells when naive but promotes their survival and function once antigen experienced: a two-faced impact on autoimmunity.Cytokine-based transformation of immune surveillance into tumor-promoting inflammation.Regulatory T cells in renal disease.Generation, persistence and plasticity of CD4 T-cell memories.Regulatory T-cell-associated cytokines in systemic lupus erythematosus.TGF-β1 as a therapeutic target for pulmonary fibrosis and COPD.Modifiers of TGF-β1 effector function as novel therapeutic targets of pulmonary fibrosisExpression of Fas ligand in activated T cells is regulated by c-Myc.Short-Lived Antigen Recognition but Not Viral Infection at a Defined Checkpoint Programs Effector CD4 T Cells To Become Protective Memory.Transforming growth factor-beta promotes 'death by neglect' in post-activated human T cells.Effect of thalidomide on apoptosis of lymphocytes and neutrophils.From naive to effector--alterations with aging.Transforming growth factor beta1 attenuates ceramide-induced CPP32/Yama activation and apoptosis in human leukaemic HL-60 cells.Immunological changes after ASIT in AD allergen-specific immunotherapy and their potential correlation with clinical response in patients with atopic dermatitis patients sensitized to house dust mite.Overexpression of transforming growth factor (TGF)-beta1 and TGF-beta3 genes in lung of toxic-inhaled patients.Proximal signaling control of human effector CD4 T cell function.Immune responses to Plasmodium falciparum-merozoite surface protein 1 (MSP1) antigen, II. Induction of parasite-specific immunoglobulin G in unsensitized human B cells after in vitro T-cell priming with MSP119.Minimal effects on immune parameters following chronic anti-TGF-beta monoclonal antibody administration to normal mice.Presence of memory T cells and naturally acquired antibodies in Plasmodium vivax malaria-exposed individuals against a group of tryptophan-rich antigens with conserved sequences.
P2860
Q24654972-E8BC0188-4D90-4971-AEB5-8902690454D7Q28245571-CE274CCA-7F88-48E8-87B6-2357E65ECA44Q30305830-4F16E003-795E-4187-ADD6-89DEE4284723Q33590992-A921A1DC-85FF-444B-9B53-6C9C26909448Q33646733-D3695C39-4A4A-4230-B643-B02CF4E57BCEQ33836328-1382DD7F-191F-48CD-A9F8-2F15AD9AF8DBQ33905248-2A5FA306-96C7-4077-919E-BF62BA05C9F2Q33945271-33221BDD-937D-4574-9799-B1F4A05ECFC4Q34099106-EB631AF0-36B2-4C9D-817B-507D17A3B08EQ34198172-D3C17D28-B063-4F82-A54A-568E8FAFC3CAQ34469408-F57CA43D-AED9-4520-8011-F0B424859B73Q34832951-F4C08576-68CB-491B-AF65-ACB5C4ACA221Q36229656-B41A390F-3A3C-4819-A901-1CCC79DFC2C7Q36366705-52F49911-53C2-478F-86E2-B8064510DA5BQ36367920-0EDAA893-7FFF-40D5-8FEF-611E889E4076Q36369531-F7D3FA47-7817-42C9-959E-5A39C8D2CC18Q36369541-EBDA7AA1-9AD2-4E45-B7DE-4E11D0897BE7Q36371590-79C3E5B6-69F6-4C9F-9E31-D7B1544401ECQ36375375-0DF1E91E-4CF1-4A24-A727-C746A84F531AQ36377260-D8B33CB1-90EF-4E29-8DCB-44C8770785C8Q36494486-EEC29BB1-46F1-4E73-A94A-112D00C5425BQ36906352-EA16D26D-77C5-4863-AEFE-D23D5473C351Q37287166-3D2BDE2C-BF26-4A39-B945-060D8E7C0AA4Q37349918-6CE0DD52-33E4-4C31-8E3B-3220AA16F2C5Q37750904-2FDC4631-9B7A-42E2-9153-2EEAE12FF3AFQ37973328-D7C68FE8-88B2-4CCA-90C9-2D9FE8C56A85Q38177343-E51D4CDD-0C11-447D-B7CA-61F8EDB9408FQ38213707-882D7038-938D-47D0-B1F9-783C56E691ACQ38313969-366B254F-5C73-4794-9D5A-AC8B52C54F2BQ40474396-768FE029-7CE5-4A3B-B78A-AC7348CF86FAQ40813238-9C24ED84-A04E-4648-88D2-87BFAE9D7FE6Q41097790-945897E2-BA35-4CC0-843D-4DE4B170CDB0Q41708745-35BEF916-172D-46BF-927A-A3F58503CDAAQ41893662-353A6A1E-69D0-4D6C-B450-58AFCBBAA197Q42692115-4D20E82A-5298-47D3-B5B5-E53B845CBA2EQ43055698-0DFB0CAE-62F3-4810-AF0A-E6A8A1AC749CQ43125271-635767A8-4736-4F02-9D06-0901AB53E5D5Q47851458-C8DF34B4-84D9-4EA8-B385-33E504526EAEQ47863292-2C766432-F918-4878-8599-1E70C243D082Q48023293-E5A52650-7076-4004-A087-E4AFA34A4FAF
P2860
Control of CD4 effector fate: transforming growth factor beta 1 and interleukin 2 synergize to prevent apoptosis and promote effector expansion
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Control of CD4 effector fate: ...... and promote effector expansion
@ast
Control of CD4 effector fate: ...... and promote effector expansion
@en
type
label
Control of CD4 effector fate: ...... and promote effector expansion
@ast
Control of CD4 effector fate: ...... and promote effector expansion
@en
prefLabel
Control of CD4 effector fate: ...... and promote effector expansion
@ast
Control of CD4 effector fate: ...... and promote effector expansion
@en
P2093
P2860
P356
P1476
Control of CD4 effector fate: ...... and promote effector expansion
@en
P2093
P2860
P304
P356
10.1084/JEM.182.3.699
P407
P577
1995-09-01T00:00:00Z